Michel M. Maharbiz is a Professor in the Department of Electrical Engineering and Computer Science at the University of California, Berkeley. He leads research on miniaturized bioelectronic interfaces, including neural dust implants and cyborg insects. He holds affiliations with the Berkeley Sensor & Actuator Center (BSAC), Center for Neural Engineering & Prostheses (CNEP), and SWARM Lab. His education includes a Ph.D. in EECS from UC Berkeley (2003) and a B.S. in EE from Cornell University (1997). Maharbiz's research integrates MEMS, ultrasonic systems, and synthetic biology to develop wireless neural interfaces, implantable sensors, and biohybrid devices. Key focus areas are neural dust technology for peripheral nerve recording, magnetoelastic strain sensors for medical applications, and electrochemical biosensing using bacterial flagellar motors. His publications emphasize neural interfaces, ultrasonic implants, and biomedical monitoring. Recent articles explore ultrasonic power delivery (2025), radiation detectors for oncology (2025), and fracture-healing smart plates (2019). Trends include miniaturization of wireless implants, closed-loop therapeutic systems, and novel biomaterials. Scientific Awards: McKnight Technological Innovations in Neuroscience Award (2017) Chan-Zuckerberg Biohub Investigator (2017) NSF CAREER Award (2009) MIT TR10 Top Emerging Technology (2009) Bakar Fellows Spark Award (2012) He directs the Maharbiz Lab, advancing neural dust and bioelectronic interfaces. Projects include impedance-based fracture monitoring, carbon fiber neural arrays, and hernia repair sensors. Funding includes NSF and industry partnerships for implantable device development.
جستجوی استاد راهنمای دانشگاهی
برای مسیر پژوهشیتان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آنها ارتباط بگیرید.
نمایش ۱-۱۵ از ۱٬۶۱۳ استاد راهنما
اطلاعات پروفایلها از صفحات عمومی دانشگاهها گرفته شده و ممکن است بهروز نباشد.
Bradley Olsen is a Professor of Chemical Engineering at the Massachusetts Institute of Technology (MIT), holding the Alexander and I. Michael (1960) Kasser Chair in Chemical Engineering. He is affiliated with MIT's School of Engineering and directs research in the Plastics and the Environment Program. His academic career spans over two decades with numerous prestigious appointments and recognitions. Olsen earned his S.B. from MIT in 2003 followed by a Ph.D. from the University of California Berkeley in 2007. His educational background is complemented by postdoctoral fellowships including NIH and Beckman Institute Postdoctoral Fellowships (2008-2009) and the Hertz Fellowship (2003-2007). Research Interests Professor Olsen's research focuses on designing materials to address important challenges while understanding the fundamental science necessary for materials design. His primary research areas include block copolymers, soft condensed matter physics, protein-based materials, and bioelectronics. His group specializes in polymer networks, protein-polymer conjugates, self-assembly phenomena, and sustainable polymer development. The research has significant implications for biomaterials, sustainable polymers, and advanced materials design. Publication Trends Analysis of Professor Olsen's recent publications reveals a strong focus on polymer network topology, protein-polymer conjugates, and sustainable materials. His work increasingly integrates computational methods with experimental approaches, particularly in polymer characterization and data science applications to materials science. Recent publications show growing emphasis on biodegradable polymers, polymer informatics, and biomedical applications of advanced materials. Scientific Recognition Professor Olsen has received numerous prestigious awards throughout his career, including: American Physical Society (APS) Fellow (2023) Fulbright Amazonia Scholar (2023) Alexander and I. Michael Kasser Chair in Chemical Engineering (2021) ACS Macro Letters/Biomacromolecules/Macromolecules Young Investigator Award (2021) AIChE Owens Corning Early Career Award (2019) American Physical Society Dillon Medal (2018) Alfred P. Sloan Research Fellow in Chemistry (2014) Advising and Funding Professor Olsen has secured significant research funding from multiple federal agencies including NSF, NIH, AFOSR, and DOE. His group has produced numerous high-impact publications across top journals in polymer science, materials science, and chemistry. He has advised multiple graduate students and postdoctoral researchers who have gone on to successful careers in academia and industry. The MIT OGE's Committed to Caring Honor (2019) recognizes his excellence in graduate student mentoring. Research Infrastructure Professor Olsen leads a research group with capabilities spanning polymer synthesis, protein engineering, materials characterization, and computational modeling. His lab maintains strong collaborations with other MIT departments, national laboratories, and international research institutions. The group participates in several interdisciplinary initiatives including the Plastics and the Environment Program and has developed significant data infrastructure for polymer science through projects like CRIPT and BigSMARTS.
Matthew L Becker is the Hugo L Blomquist Distinguished Professor of Chemistry at Duke University, with additional appointments in Mechanical Engineering and Material Science, and Biomedical Engineering. His research focuses on polymer chemistry, bioconjugate chemistry, molecular imaging, additive manufacturing, and degradable materials for bone, soft tissue, neural, and vascular tissue engineering. Education: B.S. from Northwest Missouri State University (1998), M.A. (2000) and Ph.D. (2003) from Washington University in St. Louis Research interests include developing tunable degradable polymers for flexible electronics, tissue engineering (bone, neural, vascular), and additive manufacturing. His group is pioneering 3D printing of bioresorbable medical devices and custom inks for biomaterials. Recent work explores stereochemistry-dependent polymer properties, mechanochromism, and machine learning-driven biomaterials design. Key applications: Drug delivery systems Biodegradable adhesives Tissue regeneration scaffolds Scientific honors include: Fellow, National Academy of Inventors (2022) Fellow, American Chemical Society (2020) Carl S. Marvel Award in Creative Polymer Chemistry (2019) Fellow, American Institute for Medical and Biomedical Engineering (2018) Fellow, Royal Society of Chemistry (2017) Biomacromolecules/Macromolecules Young Investigator Award (2015) He teaches advanced courses in mechanical engineering and polymer chemistry, with a focus on 3D printing and biomaterials. His group has developed novel medical devices including resorbable suture anchors, hernia mesh coatings, and neuroprosthetic scaffolds.
Kelly Arnoldمشاهده پروفایل
دانشیار
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Jered Haunمشاهده پروفایل
دانشیار
Jered Haun is an Associate Professor at the Samueli School of Engineering , University of California, Irvine , with joint appointments in Biomedical Engineering , Chemical and Biomolecular Engineering , and Materials Science and Engineering . Based in 3107 Natural Sciences II , his research focuses on developing nanoengineering and molecular medicine technologies to improve disease diagnosis and treatment. Email: jered.haun@uci.edu Phone: (949) 824-1243 Research Interests include: Nanomaterial Probes for molecular profiling and disease detection Microfabricated Platforms for cell analysis and tissue processing Targeted Delivery Carriers that interact with unique disease molecules Technologies employed in his lab encompass: Fluorescence imaging and MRI enhancements Bioorthogonal chemistry and nanosensor development Micro-NMR for tumor analysis Quantum dot-based detection systems Awards include: NIH National Cancer Institute's Innovative Molecular Analysis Technologies Funding The Haun Laboratory actively recruits graduate and undergraduate students for projects related to nanoengineering, molecular medicine, and microfluidic device development.
Christopher E. Nelson is an Assistant Professor in the Department of Biomedical Engineering at the University of Arkansas, College of Engineering. His lab focuses on developing biologically inspired strategies for controlled drug and gene delivery, particularly in the context of gene therapy and regenerative medicine. He is actively supported by the NIH, DoD, and Arkansas Bioscience Institute. Education: Postdoctoral Fellow – Duke University Ph.D. – Vanderbilt University B.S. – University of Arkansas Research Focus: Dr. Nelson’s lab integrates genome editing technologies with targeted delivery systems to address challenges in treating genetic diseases and promoting tissue regeneration. Major themes include CRISPR/Cas9 delivery , gene regulation in wound healing , and safe-harbor genome integration in skeletal muscle. His work spans viral and non-viral delivery vehicles , including lipid nanoparticles and AAV vectors, with a strong emphasis on preclinical validation in models of Duchenne muscular dystrophy and inflammatory disease. Scientific Awards: Controlled Release Society Postdoctoral Fellowship The Hartwell Foundation Postdoctoral Fellowship NIH Pathway to Independence Award (K99/R00) Funding & Support: The Nelson Lab is currently funded by: NIH NIGMS R35 DoD CDMRP DMD IDEA Award Arkansas Bioscience Institute University of Arkansas Engineering & Honors Colleges Lab & Team: The Nelson Lab is a dynamic, interdisciplinary team working at the intersection of gene editing, biomaterials, and regenerative medicine. They regularly present at national conferences such as ASGCT and NCUR, and mentor undergraduate researchers through SURF and Honors College grants.
- Gene therapy
- Regenerative medicine
- Genome editing
- +۷ مورد دیگر
Dr. William V. Giannobile serves as the Dean and A. Lee Loomis, Jr. Professor of Oral Medicine, Infection, and Immunity at Harvard School of Dental Medicine (HSDM). He leads the institution as its chief academic and administrative officer while maintaining an active research program and clinical practice in periodontics and implant dentistry at the Harvard Dental Center in Cambridge, MA. Dr. Giannobile received his DDS and MS in oral biology from the University of Missouri, followed by a certificate in periodontology and Doctor of Medical Sciences (DMSc) in oral biology from Harvard School of Dental Medicine. He completed postdoctoral training in molecular biology at the Dana-Farber Cancer Institute and Harvard Medical School. With over 30 years of continuously NIH-funded research, Dr. Giannobile's work focuses on oral and periodontal regenerative medicine, tissue engineering, and precision medicine. He serves as principal investigator of the NIDCR U-Award Harvard Clinical Practice-based Research Program for Dental Students (H-CREDENT), which evaluates the genomics of oral pain in a multi-institutional academic setting. His research has produced over 300 manuscripts, textbook chapters, and patents focused on periodontology, regenerative medicine, and oral health research. He has edited or co-edited over 10 books in clinical and translational research, periodontology, and regenerative medicine. His publications demonstrate consistent focus on periodontal regeneration, biomaterials, tissue engineering, and the molecular mechanisms underlying oral diseases. ADA Gold Medal Award for Excellence in Dental Research (2024) International Association for Dental Research Distinguished Scientist Research in Periodontal Disease Award (2022) Norton M. Ross Clinical Research Award from the American Dental Association (2018) William J. Gies Award (2014) Jan Lindhe International Periodontology Research Award (2011) As an educator and mentor, Dr. Giannobile completed a 10-year term as editor-in-chief for the Journal of Dental Research, the official journal of the International Association for Dental Research. He has served as a consultant to the U.S. Food and Drug Administration for Dental Devices and as an associate editor for the NIDCR Report on Oral Health of the U.S. in 2021. His laboratory continues to advance research in periodontal regeneration and precision medicine approaches to oral health, with ongoing NIH funding supporting innovative translational research.
Pierette Appasamy is a Lecturer in the Department of Biology at Chatham University’s College of Arts & Sciences. With a Ph.D. in Anatomy & Developmental Biology from Thomas Jefferson University, she has over three decades of experience in immunology research and education. Her career spans roles at the University of Pittsburgh School of Medicine, NIH-funded research, and current work at Chatham since 2007. B.S., Biology, cum laude, Xavier University (1982) Ph.D., Anatomy & Developmental Biology, Thomas Jefferson University (1988) Post-Doctoral Fellowship, Immunology, University of Pennsylvania (1987-1990) Her research focuses on the evolution and development of gamma delta T cells , IL-7 signaling pathways in amphibians, and psychosocial-immune interactions in college students . She employs Xenopus frogs as a model organism to study non-conventional lymphocyte biology and wound healing immunology. Recent publications highlight her work on cytokine evolution and stress-immune-microbiome dynamics , with collaborations at the University of Pittsburgh’s Center for Medicine and the Microbiome. Her pedagogical innovations include role-playing and analogies to enhance immunology education. NIH R29 Grant (Principal Investigator) NIH R01 Grant (Co-Investigator) MacArthur Foundation Grant (Yale Subcontract) American Cancer Society Grant Chatham University Technology Fellowship Award American Association of Immunologists Travel Grant She mentors students in laboratory research and serves as Chatham’s Pre-Med Advisor. Her lab combines molecular techniques, tadpole thymus microsurgery, and behavioral studies to explore immunological questions with clinical relevance.
Suradip Dasمشاهده پروفایل
استادیار
Suradip Das is a Research Assistant Professor in the Department of Neurosurgery at the Perelman School of Medicine, University of Pennsylvania, where he serves as a Senior Research Investigator. His work bridges neural engineering and regenerative medicine to address critical challenges in nerve and muscle repair. His academic training includes: B.Tech in Biotechnology from Heritage Institute of Technology (2010) PhD in Biosciences and Bioengineering from Indian Institute of Technology Guwahati (2016) Dr. Das specializes in biomaterials development , peripheral nerve injury models , neuromuscular interface engineering , and stem cell-based regeneration . His research pioneers innervated tissue-engineered muscle constructs, demonstrating how motor neurons and endothelial cells synergistically enhance skeletal myocyte maturation. He innovates custom mechanobioreactors that apply tensile forces to guide nanofiber alignment for optimal myofiber formation, significantly advancing volumetric muscle loss treatments. Analysis of his 15 most recent publications reveals a dominant focus on neuromuscular regeneration (75% of articles), with emerging exploration of psychedelic compounds in neural repair. His work consistently integrates human iPSC-derived models , multi-cellular co-cultures , and large-animal validation to address translational gaps. Key trends include optogenetic control of motor units (2023), porcine nerve injury models (2020), and the critical role of pre-innervation in creating pro-regenerative microenvironments (2020-2022). As a core member of the Cullen Lab, Dr. Das collaborates on developing biofabricated neural microtissues for delayed nerve fusion and rapid functional recovery. His research directly informs clinical strategies for peripheral nerve repair and muscle regeneration through rigorous mechanistic studies and innovative engineering solutions.
Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.
Julie C. Liuمشاهده پروفایل
دانشیار
Julie C. Liu is an Associate Professor of Chemical Engineering at Purdue University, with a courtesy appointment in Biomedical Engineering. She joined Purdue in 2008 and holds a B.S.E. from Princeton University, M.S. and Ph.D. from Caltech, and completed a postdoc at the University of Massachusetts Medical School. Her research focuses on protein-based biomaterials for tissue engineering, regenerative medicine, and surgical adhesives, with a particular emphasis on recombinant proteins and natural matrix molecules like collagen and hyaluronic acid. Key awards include the Purdue Faculty Scholar (2019-2024), ELATES Fellowship (2019), and Outstanding Mentor Award (2018). Her work has been funded by NSF, NIH, and industry grants. She advises multiple graduate and undergraduate students, mentoring over 20 researchers. Her lab collaborates on outreach, including Introduce a Girl to Engineering Day, reaching 500+ students since 2014. Liu’s lab designs biomaterials with tailored properties for cartilage repair, drug testing models, and adhesives. Recent advances include mussel-inspired adhesives and redox-responsive hydrogels. She leads a team focused on translational biomedical innovations, bridging engineering and clinical applications.
Jennifer Lewis is the Hansjorg Wyss Professor of Biologically Inspired Engineering and Jianming Yu Professor of Arts and Sciences at Harvard University's Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). Her research focuses on bioengineering, materials science, and advanced manufacturing, with emphasis on 3D-printed functional materials, organoids, and soft robotics. She leads the Lewis Research Group, which develops biomimetic technologies for regenerative medicine, energy systems, and robotics. Lewis holds appointments in SEAS, the Department of Chemistry and Chemical Biology, and the Wyss Institute for Biologically Inspired Engineering. Her research areas include applied mathematics, fluid mechanics, soft matter physics, and bioengineering applications such as kidney organoid models, vascularized tissues, and programmable materials. Notable innovations include kidney organoid-on-chip systems for drug testing, 3D-printed liquid crystal elastomers, and bioprinted cardiac tissues. Lewis was awarded the 2025 James Prize in Science and Technology Integration for pioneering interdisciplinary research. Her lab's projects span organ building blocks, immune-response modeling in transplanted tissues, and acoustophoretic printing techniques for high-resolution bioprinting. Collaborations include the NIH Somatic Cell Genome Editing Program and industry partnerships for bioprosthetic valve research. She advises on grants totaling over $20M and mentors a multidisciplinary team of postdocs and graduate students in materials science, biomedical engineering, and mechanical engineering. Lewis' lab facilities include the Pierce Hall lab (Cambridge) and Allston SEAS campus, with state-of-the-art 3D printing systems, microfluidics platforms, and bioreactors for organoid culture. Current projects aim to engineer functional human tissues for therapeutic applications and develop smart materials with programmable mechanical/chemical responses.
- Bioengineering
- Materials Science
- Soft Matter
- +۷ مورد دیگر
Theresa Raimondoمشاهده پروفایل
استادیار
Theresa Raimondo is the Manning Assistant Professor of Engineering at Brown University, with a secondary appointment in the Division of Biology and Medicine. She joined the Brown Engineering faculty in January 2024 after completing her postdoctoral training at MIT's Koch Institute. Dr. Raimondo leads the Raimondo Research Lab, which focuses on chemically modifying RNA and designing nanoparticles for therapeutic delivery to the body, an immunotherapy concept that holds immense promise in the field of immunoengineering. Her educational background includes: PhD in Engineering Sciences – Bioengineering from Harvard University (2019) MEng from Harvard University (2019) Sc.B. in Chemical and Biochemical Engineering from Brown University (2011) Dr. Raimondo's research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration. Her work primarily centers on developing novel lipid nanoparticles (LNPs) for RNA-based therapies, contributing to adjuvanted mRNA-based vaccines and siRNA-based cancer immunotherapies. By optimizing LNP formulation and modulating RNA constructs, she seeks to understand how RNA-LNPs modulate immunity and develop new therapeutic approaches. Her expertise spans biomaterials, drug delivery, biomolecular engineering, nanomedicine, tissue engineering, and regenerative medicine. Analysis of Dr. Raimondo's recent publications reveals a strong focus on RNA delivery systems and lipid nanoparticle technology. Her work spans from fundamental studies on nanoparticle design to applications in cancer immunotherapy, vaccine development, and tissue regeneration. A significant portion of her research involves optimizing lipid formulations for improved mRNA delivery and exploring how these systems interact with the immune system. Her publications demonstrate a trajectory from basic biomaterials research to increasingly translational work with therapeutic applications. Dr. Raimondo has received numerous prestigious awards: 2025 NAE Symposium selection (Grainger Foundation Frontiers of Engineering) 2025 appointment to the inaugural Early Career Board of ACS Applied Bio Materials 2024 selection as MIT Faculty Founder Initiative finalist 2022 Convergence Scholar fellowship from MIT's Marble Center for Cancer Nanomedicine National Science Foundation graduate research fellowship Harvard's Smith family graduate fellowship Dr. Raimondo is actively involved in mentoring students through courses including ENGN 0931L - Biomedical Engineering Design and Innovation II, ENGN 1490 - Biomaterials, and ENGN 1931L - Biomedical Engineering Design and Innovation II. Her research program is supported by various grants, though specific funding sources aren't detailed in the provided text. The Raimondo Research Lab represents a dynamic environment where engineering principles are applied to solve complex biological challenges in drug delivery and regenerative medicine. The Raimondo Research Lab at Brown University serves as a hub for innovation in RNA delivery and biomaterials design. The lab brings together expertise in chemical engineering, molecular biology, and immunology to develop next-generation therapeutic platforms. Current research directions include optimizing lipid nanoparticle formulations, exploring novel RNA modifications, and investigating immune responses to RNA therapeutics across various disease contexts.
- Biomaterials
- Drug Delivery
- RNA-based Therapeutics
- +۵ مورد دیگر
Jayne Ellisمشاهده پروفایل
استاد مدعو
Dr. Jayne Ellis, DVM, serves as Adjunct Faculty in the College of Natural Science and Mathematics at the University of Alaska Fairbanks (UAF). She concurrently works as an On-Call Wildlife Veterinarian for the Alaska Department of Fish and Game and teaches the necropsy laboratory for second-year veterinary students at UAF. Education Bachelor of Science in Wildlife Conservation Biology, Colorado State University Doctor of Veterinary Medicine (DVM), UAF-CSU Joint Program Dual residency training in Anatomic Pathology and Toxicology, Michigan State University (2 years) Fellowship year in Wildlife Pathology, University of California, Davis Research Interests Dr. Ellis’s investigative work centers on wildlife disease ecology and pathogenesis, with particular emphasis on viral infections affecting avian and mammalian species. Her recent projects investigate the spillover of highly pathogenic avian influenza A(H5N1) from birds into wild terrestrial mammals, as well as emerging respiratory viruses in Alaskan moose populations. Additional interests span toxicologic pathology, infectious disease surveillance in raptor populations, and comparative anesthesia protocols for endangered equids. Publications & Scientific Contributions Across 15 peer-reviewed articles and conference presentations from 2018-2023, Ellis has advanced understanding of viral transmission at the wildlife–domestic animal interface, described novel bacterial pathogens in wild birds, and refined anesthetic techniques for exotic ungulates. Her work integrates field surveillance, molecular diagnostics, and classic pathology to inform conservation and public health policy. Professional Licenses & Qualifications State of Alaska Veterinary License (active) Residency-trained and board-eligible in Anatomic Pathology Teaching & Outreach At UAF, Dr. Ellis leads hands-on necropsy laboratories that train future veterinarians in systematic post-mortem examination techniques essential to wildlife disease investigation. She also provides diagnostic pathology support to state wildlife agencies and collaborates with multi-institutional teams to monitor emerging zoonoses.
Amy Catherine Rowat is a full Professor in the Department of Integrative Biology and Physiology at UCLA's College of Letters and Science. She directs an interdisciplinary research program that integrates mechanobiology, microfluidics, cancer biophysics and food engineering to understand how physical forces shape cell behavior and to develop sustainable biotechnologies. Education & Affiliations: Professor, Department of Integrative Biology and Physiology, UCLA Member, UCLA College of Letters and Science Research Interests: Rowat's group deciphers how mechanical properties of cells and their nuclei influence disease progression and therapeutic response. Using high-throughput microfluidic deformability cytometry, her team discovered that cancer cells become stiffer and more invasive upon β-adrenergic signaling, linking stress hormones to metastatic potential. Parallel efforts focus on nuclear envelope mechanics, showing that histone H1.0 and transient nuclear deformation modulate chromatin structure and cell reprogramming. Beyond biomedicine, Rowat pioneers biophysical approaches for sustainable food production. She engineers edible scaffolds and emulsion-templated microcarriers to culture meat at scale, demonstrating spontaneous fusion of adipogenic and myogenic microtissues into marbled steak-like constructs. Recent Article Trends (2020-2025): Her latest publications reveal a cohesive trajectory: coupling mechanobiology to epigenetic regulation (viscoelastic matrix enhances chromatin remodeling), advancing single-cell mechanical phenotyping (optomagnetic arrays, high-throughput screens), translating findings to cancer therapy (β-blockers to sensitize chemotherapy) and expanding engineered foods (scalable cultured-meat bioprocessing). Funding & Awards: NIH R21 CA245667 (PI) – Repurposing beta-blockers to improve chemotherapy response (2021-2023) Laboratory & Teams: Rowat leads an active research laboratory at UCLA that trains graduate students and postdocs at the intersection of physics, engineering and biology. The lab maintains collaborations across UCLA Engineering, Jonsson Comprehensive Cancer Center, and external partners in food science and biotechnology companies.
نمایش نتایج تا ۷۵۰ مورد اول. برای یافتن نتایج دقیقتر، جستجوی خود را با فیلترها محدود کنید.